Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gianni

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Journal of Chemotherapy (Florence, Italy)|June 1, 1994
Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancerM Scarpellini, A Tononi, E Pasquini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding studyL Gianni, E Munzone, G Capri, et al.
British Journal of Clinical Pharmacology|January 13, 2015
Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)M Joerger, D Hess, A Delmonte, et al.
Journal of the National Cancer Institute|August 2, 1995
Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclinesL Gianni, E Munzone, G Capri, et al.
British Journal of Haematology|April 1, 1990
Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivoL Gugliotta, A D'Angelo, M Mattioli Belmonte, et al.
Breast Cancer Research and Treatment|January 24, 2002
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancerG Mariani, P Tagliabue, P Zucchinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growthN Normanno, M Campiglio, Luca A De, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.
Seminars in Oncology|November 28, 1997
Paclitaxel plus doxorubicin in breast cancer: an Italian experienceG L Frassineti, W Zoli, L Silvestro, et al.
International Journal of Cancer|November 15, 1988
Monoclonal antibodies against doxorubicinA Balsari, R Alzani, D Parrello, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Journal of Chemotherapy (Florence, Italy)|June 1, 1994
Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancerM Scarpellini, A Tononi, E Pasquini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding studyL Gianni, E Munzone, G Capri, et al.
British Journal of Clinical Pharmacology|January 13, 2015
Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)M Joerger, D Hess, A Delmonte, et al.
Journal of the National Cancer Institute|August 2, 1995
Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclinesL Gianni, E Munzone, G Capri, et al.
British Journal of Haematology|April 1, 1990
Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivoL Gugliotta, A D'Angelo, M Mattioli Belmonte, et al.
Breast Cancer Research and Treatment|January 24, 2002
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancerG Mariani, P Tagliabue, P Zucchinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growthN Normanno, M Campiglio, Luca A De, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.
Seminars in Oncology|November 28, 1997
Paclitaxel plus doxorubicin in breast cancer: an Italian experienceG L Frassineti, W Zoli, L Silvestro, et al.
International Journal of Cancer|November 15, 1988
Monoclonal antibodies against doxorubicinA Balsari, R Alzani, D Parrello, et al.
Pageof 11